本次回购符合公司回购股份方案及相关法律法规的要求。 | 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-069 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于回购股份进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召 开第六届董事会第十一次会议、第六届监事会第十一次会议，于 2024 年 5 月 14 日召开 2024 年第一次临时股东大会，审议通过了《关于回购公司股份方案的议 案》，同意公司使用自有资金以集中竞价交易方式回购公司已发行的部分人民币 普通股（A 股）股份（以下简称"本次回购"），本次回购股份将予以注销并相应 减少公司注册资本。本次回购资金总额不低于人民币 10,000 万元（含本数）且不 超过人民币 20,000 万元（含本数），具体回购资金金额以回购实施完成时实际回 购的金额为准。本次回购价格不超过人民币 45 元/股（含本数）。具体内容 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-068 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于召开2024年第三次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）于2024年8月20日在巨潮 资讯网（http://www.cninfo.com.cn）上刊登了《关于召开2024年第三次临时股东大 会的通知》（公告编号：2024-067），定于2024年9月5日召开公司2024年第三次 临时股东大会，本次会议将采取现场投票与网络投票相结合的方式，为切实保护 广大投资者的合法权益，方便公司股东行使表决权，现将本次股东大会的有关事 宜提示如下： 一、召开会议基本情况 1、股东大会届次：2024年第三次临时股东大会 2、会议召集人：公司第六届董事会 3、会议召开的合法、合规性：公司于2024年8月16日召开的第六届董事会 第十四次会议审议通过了《关于召开2024年第三次临时股东 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company, with a target price of 38.87 CNY, compared to the current price of 31.16 CNY [1]. Core Insights - The company reported a revenue of 3.582 billion CNY for H1 2024, a year-on-year increase of 4.35%. However, the net profit attributable to shareholders decreased by 19.54% to 416 million CNY [1]. - In Q2 2024, the company achieved a revenue of 2.067 billion CNY, a quarter-on-quarter increase of 36.41%, and a net profit of 251 million CNY, up 51.97% quarter-on-quarter [1]. - The company is actively expanding its overseas market presence and developing organic fluorine products across multiple sectors, indicating a positive growth trajectory [1]. Financial Performance Summary - For H1 2024, the company’s revenue was 3.582 billion CNY, with a net profit of 416 million CNY, and a non-recurring net profit of 431 million CNY, reflecting a 10.02% year-on-year increase [1]. - The company’s battery chemicals business generated 2.29 billion CNY in revenue, a 4.44% year-on-year increase, despite a decline in product prices [1]. - The report forecasts net profits for 2024-2026 to be 1.064 billion CNY, 1.465 billion CNY, and 1.873 billion CNY, respectively, with corresponding EPS of 1.41 CNY, 1.94 CNY, and 2.48 CNY [2][1]. Market Position and Strategy - The company has successfully established a global production capacity and is focusing on enhancing its market position in the lithium battery electrolyte sector [1]. - A significant supply agreement with European clients is expected to contribute approximately 6.76 billion USD to the company’s revenue from 2024 to 2035 [1]. - The company is also adjusting its organic fluorine product structure to meet the growing demand in various downstream sectors, including pharmaceuticals and new energy [1].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown significant growth in Q2 2024, with a revenue increase of 36.41% quarter-on-quarter, driven by the expansion of organic fluorochemical products [5][6] - The overall performance in the first half of 2024 was impacted by a slowdown in the new energy sector, increased competition in lithium battery materials, and declining product prices [4][5] Financial Performance Summary - In H1 2024, the company achieved a total revenue of 3.582 billion yuan, a year-on-year increase of 4.35%, but the net profit attributable to shareholders decreased by 19.54% to 416 million yuan [3][4] - Q2 2024 results showed a revenue of 2.067 billion yuan, up 15.75% year-on-year and 36.41% quarter-on-quarter, with a net profit of 251 million yuan, reflecting a year-on-year decrease of 7.54% but a quarter-on-quarter increase of 51.97% [3][5] Segment Performance Summary - Battery chemicals generated revenue of 2.293 billion yuan, up 4.44% year-on-year, with a gross margin of 13.65% [4] - Organic fluorochemicals reported revenue of 712 million yuan, down 4.72% year-on-year, with a gross margin of 62.22% [4] - Capacitor chemicals saw revenue of 365 million yuan, an increase of 20.07% year-on-year, with a gross margin of 40.48% [4] - Semiconductor chemicals achieved revenue of 177 million yuan, up 15.98% year-on-year, with a gross margin of 44.86% [4] Future Outlook - The company is expected to benefit from the exit of 3M from PFAS production, which may create opportunities in the organic fluorochemical market [6] - Revenue projections for 2024-2026 are estimated at 8.216 billion, 10.114 billion, and 12.911 billion yuan respectively, with net profits of 1.094 billion, 1.527 billion, and 2.014 billion yuan [7][16]

[Table_MainInfo] 公司研究/化工/基础化工材料制品 证券研究报告 新宙邦（300037）公司半年报点评 2024 年 08 月 23 日 [Table_InvestInfo] 投资评级 优于大市 维持 股票数据 | --- | --- | |------------------------------------------------|--------------| | 08[Table_StockInfo 月 22日收盘价（元）] | 31.12 | | 52 周股价波动（元） | 27.18-50.60 | | 总股本/流通 A 股（百万股） | 754/547 | | 总市值/流通市值（百万元） | 23461/17014 | | 相关研究 | | | [Table_ReportInfo] 《2023 年归母净利润同比减少 | 42.50%，氟化 | 工业务快速增长》2024.04.05 市场表现 [Table_QuoteInfo] 新宙邦 海通综指 -41.69% -32.69% -23.69% -14.69% -5.69% 3.31% 2023/8 2023/11 2024/2 2 ...

电力设备 2024 年 08 月 22 日 新宙邦 (300037) ——业绩符合预期，电解液海外工厂放量，氟化工格局优 化逻辑不变 | --- | --- | |------------------------------------|---------------------| | 市场数据： | 2024 年 08 月 21 日 | | 收盘价（元） | 31.76 | | 一年内最高/最低（元） | 50.60/27.18 | | 市净率 | 2.7 | | 息率（分红/股价） | 1.89 | | 流通 A 股市值（百万元） | 17,364 | | 上证指数/深证成指 | 2,856.58/8,229.75 | | 注："息率"以最近一年已公布分红计算 | | | --- | --- | |--------------------------|---------------------| | 基础数据: | 2024 年 06 月 30 日 | | 每股净资产（元） | 11.89 | | 资产负债率% | 41.38 | | 总股本/流通 A 股（百万） | 754/547 | | 流通 B 股 ...

[Table_Main] 证券研究报告 | 公司点评 新宙邦(300037.SZ) 2024 年 08 月 21 日 买入（维持） 所属行业：电力设备/电池 当前价格(元)：31.76 证券分析师 彭广春 资格编号：S0120522070001 邮箱：penggc＠tebon.com.cn 赵皓 资格编号：S0120524030004 邮箱：zhaohao3＠tebon.com.cn 市场表现 新宙邦 沪深300 -60% -40% -20% 0% 20% 2023-08 2023-12 2024-04 | --- | --- | --- | --- | |-------------|-------|-------|-------| | 沪深300对比 | 1M | 2M | 3M | | 绝对涨幅(%) | -3.29 | -2.10 | -4.96 | | 相对涨幅(%) | 1.36 | 3.22 | 3.77 | 资料来源：德邦研究所，聚源数据 相关研究 1.《新宙邦（300037.SZ）：电解液盈利 承压，氟化工开启强成长周期》， 2024.5.7 2.《新宙邦（300037.SZ）：盈利承压， 追 ...

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company reported a significant quarter-on-quarter increase in Q2 2024, with revenue reaching 2.07 billion yuan, a year-on-year increase of 15.8% and a quarter-on-quarter increase of 36.4% [1] - The organic fluorine segment faced temporary pressure, but the growth trend for second and third-generation products remains positive [1] - The company is expected to see a gradual increase in production capacity for key products, particularly in the organic fluorine sector, as new projects come online [1] Financial Performance Summary - For H1 2024, the company achieved revenue of 3.58 billion yuan, a year-on-year increase of 4.4%, while net profit attributable to shareholders was 416 million yuan, a year-on-year decrease of 19.5% [1] - The organic fluorine chemical segment generated revenue of 710 million yuan in H1 2024, a year-on-year decrease of 4.7% [1] - The capacitor chemicals segment saw revenue of 365 million yuan, a year-on-year increase of 20.1%, with a gross margin of 40.5% [1] - The battery chemicals segment reported a production volume of 157,000 tons, a year-on-year increase of 87%, with revenue of 2.29 billion yuan, a year-on-year increase of 4.4% [1] Future Earnings Projections - The company is projected to achieve net profits of 1.08 billion yuan, 1.60 billion yuan, and 2.24 billion yuan for the years 2024, 2025, and 2026 respectively, corresponding to P/E ratios of 21.9, 14.7, and 10.5 times [1][2]

电解液产能全球化布局，氟化工打造新成长曲线 2024 年 08 月 21 日 ➢ 事件。2024 年 8 月 19 日，公司发布 2024 年中报。24 年 H1 公司实现营 收 35.82 亿元，同增 4.35%，实现归母净利 4.16 亿元，同减 19.54%，扣非后 归母净利 4.31 亿元，同减 10.02%。 ➢ Q2 业绩拆分。营收和净利：公司 2024Q2 营收 20.67 亿元，同增 15.75%， 环增 36.41%，归母净利润为 2.51 亿元，同减 7.54%，环增 51.97%，扣非后归 母净利润为 2.47 亿元，同减 1.38%，环增 34.63%。毛利率：2024Q2 毛利率为 28.37%，同减 2.03pcts，环增 1.16pcts。净利率：2024Q2 净利率为 12.36%， 同减 3.01pcts，环增 1.60pcts。费用率：公司 2024Q2 期间费用率为 13.37%， 同比 0.97pct，其中销售、管理、研发、财务费用率分别为 1.76%、6.99%、4.53%、 0.09%，同比变动 0.21pct、2.10pcts、-2.31 pcts 和 0.96 ...

[Table_StockNameRptType] 新宙邦（300037） 公司点评 电解液拖累公司业绩，氟化工助力成长 | --- | --- | |------------------------------|-------------| | [Table_Rank] | | | 报告日期： | | | [Table_BaseData]收盘价（元） | 31.32 | | 近 12 个月最高/ | 50.60/27.18 | | 总股本（百万股） | 754 | | 流通股本（百万股） | 546 | | 流通股比例（%） | 72.46 | | 总市值（亿元） | 236 | | 流通市值（亿元） | 171 | [公司价格与沪深 Table_Chart] 300 走势比较 -52% -36% -20% -3% 13% 8/23 11/23 2/24 5/24 新宙邦 沪深300 [Table_Author] 分析师：王强峰 执业证书号：S0010522110002 电话：13621792701 邮箱：wangqf@hazq.com 分析师：刘旭升 执业证书号：S0010524070003 电话：1761 ...